Cytokine signaling from the tumor microenvironment can allow leukemia cells to survive targeted imatinib therapy, in the first report of a non-autonomous resistance mechanism.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cancer: evolutionary, genetic and epigenetic aspects
Clinical Epigenetics Open Access 14 September 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Druker, B.J. et al. N. Engl. J. Med. 344, 1031–1037 (2001).
Gorre, M.E. et al. Science 293, 876–880 (2001).
Shah, N.P. et al. Cancer Cell 2, 117–125 (2002).
Cools, J. et al. N. Engl. J. Med. 348, 1201–1214 (2003).
Pao, W. et al. PLoS Med. 2, e73 (2005).
Shah, N.P. et al. Science 305, 399–401 (2004).
Talpaz, M. et al. N. Engl. J. Med. 354, 2531–2541 (2006).
Williams, R.T., den Besten, W. & Sherr, C.J. Genes Dev. 21, 2283–2287 (2007).
Williams, R.T., Roussel, M.F. & Sherr, C.J. Proc. Natl. Acad. Sci. USA 103, 6688–6693 (2006).
Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A. & van Lohuizen, M. Nature 397, 164–168 (1999).
Park, I.K. et al. Nature 423, 302–305 (2003).
Engelman, J.A. et al. Science 316, 1039–1043 (2007).
Mellinghoff, I.K. et al. N. Engl. J. Med. 353, 2012–2024 (2005).
Wendel, H.G. et al. Proc. Natl. Acad. Sci. USA 103, 7444–7449 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawyers, C. Where lies the blame for resistance—tumor or host?. Nat Med 13, 1144–1145 (2007). https://doi.org/10.1038/nm1007-1144
Issue Date:
DOI: https://doi.org/10.1038/nm1007-1144
This article is cited by
-
Drug-tolerant insurgents
Nature (2010)
-
Cancer: evolutionary, genetic and epigenetic aspects
Clinical Epigenetics (2010)